International Isotopes Rebrands as Radnostix, Focusing on Theranostics and Radioisotope Solutions
- International Isotopes Inc. has rebranded as Radnostix, Inc. to reflect its focus on radioisotopes and theranostics.
- Radnostix aims to leverage expertise in radioisotope manufacturing to meet growing demands in personalized medicine solutions.
- The company retains core operations and branding while continuing to trade under the ticker symbol "INIS."
Radnostix, Inc.: A New Era for International Isotopes in Theranostics and Radioisotope Solutions
International Isotopes Inc. has officially rebranded itself as Radnostix, Inc., a strategic move aimed at aligning its identity with its expanded focus on radioisotope and theranostics solutions. Established in 1995, the company has evolved beyond its original mandate of solely manufacturing industrial radioisotope products. CEO Shahe Bagerdjian states that the new name encapsulates their commitment to being a leading partner in the radioisotope and theranostics market. The rebranding reflects a significant shift in the company's mission, emphasizing quality, innovation, and customer service in a growing field that is crucial for advancements in medical diagnostics and treatment.
The rebranding comes at a pivotal time when theranostics—an integrated approach combining therapeutics and diagnostics—are gaining traction in the healthcare sector. Radnostix aims to leverage its extensive expertise in manufacturing radioisotope products, such as sodium iodide I-131, which plays a vital role in treating hyperthyroidism and thyroid cancer. The company's commitment to delivering high-quality radioisotope APIs for third-party clients in the theranostics arena positions it well to meet the increasing demand for personalized medicine solutions. This strategic focus allows Radnostix to remain competitive in an industry that is rapidly evolving, driven by technological advancements and a growing emphasis on precision medicine.
Despite the name change, core operations, management, and strategic direction remain intact, ensuring continuity for clients and stakeholders. The company retains its INIS branding for specific segments that focus on high-energy sources, bulk radioisotopes, and stable isotopes, providing a clear delineation of its diverse offerings. In addition to its flagship products, Radnostix continues to operate its established brands, including Radqual, Radvent, Easyfill, Benchmark, and PhanQual, allowing it to maintain a robust portfolio of services tailored to various market needs. The headquarters is based in Idaho Falls, Idaho, where the company emphasizes its dedication to quality and innovation.
In related developments, Radnostix assures shareholders that no action is required on their part regarding stock certificates due to the name change. The company's common stock will continue to trade under the ticker symbol "INIS" on the OTCQB marketplace, with any potential updates regarding a new ticker symbol to be announced in the future. For further details about their products and services, stakeholders are encouraged to visit the newly revamped website, radnostix.com.